CEO Rick Pierce to deliver an investor presentation on Thursday, October 1 in New York CEO Rick Pier

Once-Weekly Intranasal Potential : Preclinical PK data demonstrate single-dose drug levels sustained

Gainers Kodiak Sciences (NASDAQ:KOD) shares moved upwards by 172.3% to $88.08 during Monday's r

Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regula

Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market sessi

Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REI

HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "D

Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 32.2% to $45.56 during Tuesday's af

U.S. stocks were mixed: Nasdaq and S&P 500 rose while the Dow fell; communication services gaine

Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular

Decoy Therapeutics, Inc. (NASDAQ:DCOY) ("the Company" or "Decoy"), a biotechnology c

HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) ("the Company" or "D

U.S. stocks rose Tuesday: Dow +0.24%, Nasdaq +0.39%, S&P 500 +0.18%. Communication services led;

Gainers Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market

Decoy Therapeutics, Inc. (NASDAQ:DCOY), a biotechnology company pioneering Designable Multi-Antivira

Next-Generation D-MAVs™ Demonstrate Potent In Vitro Activity Against Ebola Zaire and Marburg Viruses

Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a

Gainers Modular Medical (NASDAQ:MODD) shares increased by 11.3% to $3.14 during Wednesday's pre

Rick Pierce, Chief Executive Officer, to deliver an investor presentation on Thursday, September 10

Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, pr

Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, pr

Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular

 Building on the result, Decoy has opened an exploratory program to design D-MAVs against filoviruse

Lead D-MAV demonstrates cross-viral family fusion inhibition, validating theplatform; opens a new pr

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnol

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s

AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financi

Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 poi

Decoy Therapeutics Inc. (NASDAQ:DCOY) shares are trading higher. The company announced a $21 million

Decoy Therapeutics shares are surging Monday after a $21 million private placement financing with a

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&

CMCSA: 25% | Comcast To Separate Into Two Independent Publicly Traded Companies Through Tax-Free Spi

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing PR Newswire HOUSTON

HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "De

Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for dis

CAMBRIDGE, Mass., June 3, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnolo

hVIVO PLC's (AIM:HVO) consultancy contract with Decoy Therapeutics, announced on Monday, is a small

hVIVO PLC (AIM:HVO), the clinical development company specialising in human challenge trials, has si

Collaboration supports Phase 1 and Phase 2a human proof-of-concept studies for new antiviral categor

Appointment deepens scientific leadership as Decoy advances its Designable Multi-Antiviral pipeline

Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the ana

CBO Peter Marschel to Lead HubXchange Roundtable on Computational Peptide Design CSO Dr. Barbara Hib